Gyre Therapeutics, Inc.GYRENASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank7
3Y CAGR-25.4%
5Y CAGR-24.3%
Year-over-Year Change
Price-to-book ratio
3Y CAGR
-25.4%/yr
vs +6.7%/yr prior
5Y CAGR
-24.3%/yr
Consistent
Acceleration
-32.1pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.95 | -63.4% |
| 2024 | 16.26 | +116.4% |
| 2023 | -98.95 | -789.7% |
| 2022 | 14.35 | +40.9% |
| 2021 | 10.18 | -57.3% |
| 2020 | 23.86 | +33.0% |
| 2019 | 17.94 | +62.2% |
| 2018 | 11.06 | -53.9% |
| 2017 | 23.98 | +238.4% |
| 2016 | 7.09 | - |